FSRH Annual Scientific Meeting (ASM) 2023: Visions for the future | Glasgow and virtual

Dr Janet Barter, President of FSRH

Following undergraduate training in Sheffield, Janet switched to obstetrics and gynaecology from GP training after realising from work in UK and West Africa the crucial importance of women’s health.

Training in O&G included endocrinology, fertility, menopause, PMS, menstrual disorders and medical gynaecology, as well as contraception and abortion.

She has expertise in sexual problems work and care of women who have been affected by FGM. During three London Consultant SRH posts Janet has developed clinical and teaching skills across the whole of SRH, and is now Training Programme Director for CSRH in London, and she was Chair of FSRH’s Specialty Advisory Committee. 

Dr Helen Munro

Helen is a Consultant and Clinical Lead in Community Sexual and Reproductive Healthcare within Hywel Dda University Health Board, SW Wales. She is FSRH Vice President (Quality) and has had a varied career to date beginning in Scotland, where she graduated from Dundee University. She completed training in General Practice there, before moving to work in Namibia South West Africa. On her return to the UK she completed an MSc in Public Health at LSHTM before taking up a role in North London within a integrated contraception and sexual health clinic. This is where she found her niche and pursued the CESR route to becoming a Consultant in Community Sexual and Reproductive Healthcare completing in 2017.

Dr Maryam Nasri

Maryam Nasri is a Community Sexual and Reproductive Healthcare consultant and a GP in London and has worked in primary care as a GP and in contraception as a specialist for 17 years.  She has worked in primary care, community settings and acute care with a variety of providers. She has worked in many services such as menopause clinics, complex contraception clinics, and integrated clinics with GUM specialists and as a sexual assault officer. Her experience enables her to deliver a holistic and life course approach in her clinical work and gives her a broad insight into delivery of care, patient needs and clinicians’ needs, in primary and specialist care. She has been a faculty trainer for more than ten years, training a wide variety of healthcare professionals in different settings. She has been the VP for membership since 2021 and is responsible for ensuring the FSRH continues to support its members in all categories. She oversees the work of the events and the international committee. 

Professor Anna Glasier OBE

Women’s Heath Champion for Scotland and Honorary Professor, Centre for Reproductive Health at the University of Edinburgh.

Prof Anna Glasier DSc, OBE is an internationally renowned physician in the field of reproductive medicine. Prof Glasier was appointment the First Women’s Health Champion for Scotland by the Scottish Government in January 2023.

Professor Glasier has been instrumental in identifying and implementing changes to policies and services to better meet the needs of women in Scotland. She is an expert on emergency contraception, her work has been instrumental in making emergency contraception available in the UK and other countries without medical prescription. More recently she has been working to get a daily oral contraceptive pill approved without prescription – an effort which met with success in the UK in 2021.

Over the course of her career, Professor Glasier has held a number of positions including clinical scientist at the Medical Research Council Unit of Reproductive Biology, Director of Family Planning and Well Woman Services at NHS Lothian and Lead Clinician for Sexual Health. Her research specialities are reproductive health, particularly contraception and abortion, and she has worked with international organisations, including the Population Council in New York, and the World Health Organization. Prof Glasier continues to be active in her field although she has now retired from clinical work.

Dr Claire Martin

Dr Claire Martin is a historian of gender, sexuality and health in modern Britain. She is a Research Fellow at the University of Birmingham currently working on a UKRI-funded project called ‘Histories of Sexual Health in Britain’. This project maps sexual health histories from the end of the First World War to the beginning of the AIDS crisis, and brings those histories to bear on health challenges and inequalities facing society today. 

Dr Jennifer Hall PhD MBChB MFPH

Jennifer Hall is a Clinical Associate Professor and NIHR Advanced Fellow at the UCL Institute for Women’s Health, and an Honorary Consultant in Public Health Medicine at UCLH and OHID. A public health doctor by background, she is a mixed-methods researcher with skills and expertise in quantitative, qualitative and psychometric methodologies and holds a PhD in Maternal Health and Epidemiology. She has national and international experience of working with clinical, public health and academic colleagues, particularly around the measurement of pregnancy intention, preconception care and the detection and management of unplanned pregnancies, bringing a lifecourse approach to reproductive health services and research.

Professor Jill Shawe

Jill Shawe is a clinical academic nurse/midwife and Professor of Maternal and Family Healthcare at the University of Plymouth. Jill has extensive experience in the field of women's healthcare and in research and education in periconception care. Jill is Chair of the Faculty of Sexual and Reproductive Health (FSRH) Research Group, and a member of the Advisory Group for Contraception ((AGC) in England.

Polly Zipperlen MSc, RGN, RNT

Polly is a Sexual Health Sister, working in rural West Wales. She holds LoC in IUD and Implants, as well as being a Faculty Registered Trainer and Registered Nurse Tutor. She has a Masters in Enhanced Nursing Practice with a specialist interest in developing advanced clinic expertise among nurses.

Polly has recently become a sister in the Welsh Gender Service and guest lectures on the BSc Nursing (Adult) course at Aberystwyth University.

Polly is Co-Chair of the FSRH Events Committee and Secretary to BASHH Wales.

Ruth Bailey 

Ruth is an Advanced Nurse Practitioner in Sexual Health working in Primary Care. She is an experienced LARC Fitter, Independent Prescriber and Faculty Registered Trainer and is currently working towards an advanced certificate in Principles and practice of Menopause Care.  Through her work on the RCN Women's Health Forum she has contributed to a broad range of publications and resources and as the FSRH Council Nurse Representative she seeks to amplify nurse engagement within the Faculty. 

Dr Rebecca French

Dr Rebecca French, Associate Professor in Sexual & Reproductive Health Research (SRHR), London School of Hygiene & Tropical Medicine (LSHTM). A Public Health researcher with over 30 years of experience in policy-related research, mixed methods, survey design, intervention design and evaluation of complex interventions. Interests include how preferences affect choice in healthcare, specifically around fertility-related decision-making, and how new technologies and models of care can be used to promote better SRH. Currently, co-Principal Investigator on the National Institute of Health Research funded SACHA (Shaping Abortion for Change) study to examine how health services be best configured in the UK in response to the decriminalisation and de-medicalisation of abortion to provide quality, evidence-based care and services.  Principal Investigator on the Department of Health and Social Care funded National Women’s Reproductive Health Survey, designed to monitor trends in health and well-being across the reproductive life course. Member of the Faculty of Sexual and Reproductive Healthcare (FSRH) Research Group and Chair between 2017-22. Awarded an Honorary Fellowship with the FSRH in 2021 for her contribution to research.  

Dr Julia Bailey

Julia Bailey a sexual health specialty doctor in South East London, and senior academic at University College London.

Julia's research and teaching focus on digital health (e.g. the Contraception Choices website) and sexual health in society - understanding sexual health in the context of power dynamics.

Dr Charlotte Porter

Charlotte’s interest in sexual health began in Liverpool, and she subsequently worked in Edinburgh, Bristol and Oxford, completing a CCT in obstetrics and gynaecology before undertaking top-up training in community gynaecology. Charlotte has been a consultant in community sexual and reproductive healthcare (community gynaecology) since 2001, working both in primary and secondary care. She has experienced first-hand how the changes in commissioning and service integration have affected those practising in the specialty.  

Charlotte has been a specialty trainer since 2002 when she set up a sub-specialty programme in Nottingham and she is now a TPD for East Midlands and Yorkshire and was previously the Chair of the specialty advisory committee at FSRH.  

Dr Katie Boog

Katie is Co-Director of the CEU, leading on guidance dissemination and guidance related education and she recently led the development of the CEU's new Intrauterine Contraception Guideline. Her special interests include complex contraception and medical education, and she is particularly interested in making guidance accessible and relatable to clinicians. 

Katie began her career as a Registrar in Sexual Health and HIV in Australia, before returning to the UK to undertake CSRH training in the East Midlands. In addition to her CEU role, Katie works as a consultant in Community Sexual and Reproductive Health in NHS Lothian and as an Honorary Senior Lecturer at the University of St Andrews.

Claire Nicol

Claire is the Deputy Director of the CEU, leading on nursing and midwifery engagement and also quality assurance of clinical content of educational and guidance products. She led on the development of the recently published Progestogen-only Pills guideline.

Claire began her career as a midwife, before moving into SRH 15 years ago and she currently works as an Advanced Nurse Practitioner in Sexual and Reproductive Health at Chalmers Centre in Edinburgh. She has a special interest in complex contraception and nursing and midwifery education and training.

In-person & virtual access

Ticket type

Price

FSRH Member

£165.00

FSRH Concession Member (Nurses, midwives, trainees, students)

£105.00

Non-member

£215.00

Commercial company representative

£280.00

Virtual-only access

Ticket type

Price

FSRH Member

£90.00

FSRH Concession Member (Nurses, midwives, trainees, students)

£75.00

Non-member

£105.00

Conference Dinner

Conference Dinner ticket

£65

The conference dinner will take place at the Golden Jubilee Conference Hotel, Glasgow from 19:00 on Friday, 23 June 2023

Gedeon Richter

Gedeon Richter offers a comprehensive gynaecological, fertility and osteoporosis portfolio, aiming to address various women’s healthcare needs. Our ambition is to help women achieve theirs.

October 2022, UK-GED-2200083

About Bayer in Women’s Healthcare

Bayer is committed to developing innovative treatments that help improve people’s lives. With a long heritage in Women’s Healthcare, Bayer has been dedicated to offering a wide range of effective short- and long-acting contraception methods and has committed to contributing to the United Nation’s sustainability goal of increasing access to modern contraception for women through investments in R&D, innovation and supporting community efforts to eliminate access barriers.  Bayer endeavours to provide women with suitable contraception options for each life stage plus a choice of therapies for menopause management and other gynaecological conditions, including relief of heavy menstrual bleeding.

RP-MIR-GB-0128

Organon

Organon is a global healthcare company formed to focus on improving the health of women throughout their lives, working to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of therapeutic areas.

We bring these important therapies around the world, with an international footprint that serves people in more than 140 markets.  We believe the diversity of our business provides a sustainable engine of growth so we can continue to invest in and advance new medicines and treatments for women that are so urgently needed.

DOP October 2022
JBN GB-XPL-115334